Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | WRN | Q14191 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24701273 | 0.83 | TSHR (0.32) | BLMWRNTSHR | |
| SCHEMBL27251982 | 0.81 | BLM (0.31) | BLMWRN | |
| SCHEMBL21345397 | 0.79 | BLM (0.39) | BLMWRN | |
| SCHEMBL9724425 | 0.73 | SMN1; SMN2 (0.35) | TSHR | |
| SCHEMBL9294282 | 0.71 | GAA (0.40) | TSHR | |
| SCHEMBL12228960 | 0.69 | BLM (0.34) | BLMWRNTSHR | |
| SCHEMBL21067598 | 0.68 | ALDH1A1 (0.33) | BLMWRN | |
| SCHEMBL15541204 | 0.68 | CYP3A4 (0.44) | BLMWRN | |
| SCHEMBL24977052 | 0.66 | MEN1 (0.30) | — | |
| SCHEMBL13156166 | 0.66 | GAA (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338564-A1 | NEODEGRADER CONJUGATES | ORUM THERAPEUTICS, INC. (FR) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338564-A1 | NEODEGRADER CONJUGATES | CD44, FOLR1, CD47 | BLM 506/4885WRN 1709/4885TSHR 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.